Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...

A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...

A brand-name drug is the original version of a medication that’s FDA-approved to treat a specific condition. Generics contain exact copies of the active ingredient in the original branded drug (an ...

More than half of the drugs listed on the new TrumpRx website have a cheaper generic version on the market that can be purchased through other direct-to-consumer sites. Why it matters: Patients could ...

Investors are still coming out of one of the worst bond markets in history. Between the bond market’s dismal 2022 and the stock market’s downturn from the onset of the Russia-Ukraine war, the 2020s ...

TADCO posts losses of SAR 49.2M in 9M 2025, SAR 24.1M in Q3 9 M 2025 TADCO incurs SAR 25.1M loss in H1 2025, SAR 18M in Q2 6 M 2025 TADCO trims losses to SAR 7.1M in Q1 2025 3 M 2025 TADCO loses SAR ...

With a single click, unlock detailed, AI-assisted insights pulled from hundreds of financial data points instantly.

To cite GenericML in publications, please use: If you experience any bugs or issues or if you have any suggestions for additional features, please submit an issue via the Issues tab of this repository ...

Search and compare thousands of stocks at US News Best Stocks ...